Exclusive: PCTs 'blacklist' drugs backed by NICE

GPs have been barred from prescribing drugs recommended by NICE because PCTs have 'blacklisted' the treatments to cut costs.

Fourteen drugs recommended in NICE appraisals have been blacklisted by PCTs (Photograph: Istock)

A GP investigation revealed that one in four PCTs now blacklist drugs backed by NICE. Drugs on the lists are 'not recommended for use' or 'not prescribable' because they are deemed too expensive or not effective enough.

The NHS Constitution gives patients the right to receive any drug recommended in NICE technology appraisals if their doctor believes it is clinically appropriate.

But 14 drugs recommended in NICE appraisals, and a further five drugs backed in NICE clinical guidance, have been blacklisted by PCTs. These include drugs for cardiovascular and GI disorders, asthma and diabetes.

Of 71 PCTs responding to a Freedom of Information Act request, 33 (46%) have introduced 'black' or 'double red' lists of treatments not recommended for use. Nineteen of these include drugs recommended by NICE.

PCT blacklists are an extension of 'traffic light' systems that indicate drugs' suitability for use in primary care and other clinical settings.

GPC negotiator Dr Chaand Nagpaul said PCTs blacklisting NICE-approved drugs were failing in duties to patients. 'If an area is blacklisting a NICE-approved drug, it is breaking its duty of care. It is falling foul of the whole purpose of NICE recommendations.'

The charity Heart UK said blacklists undermined NICE's role and risked increasing postcode prescribing. 'Postcode prescribing may lead to further variation in heart attacks and strokes,' said its medical and scientific research committee chairman Dr Nigel Capps.

Gavin Terry, policy manager at Diabetes UK, said patients' health must not be compromised by cutting spending on NICE-approved drugs.

Manchester GP Dr Anita Sharma, a member of Oldham medicines management committee, said prescribing costs needed to be contained to help meet productivity targets. But restrictions must be agreed between GPs, PCTs and the public and focus on drugs with low clinical value, she said.

Dr Anita Sharma: 'If drugs are restricted because of low clinical priority, we should have no objection'

'If drugs are restricted because of low clinical priority, for example, erectile dysfunction drugs and some non-steroidal medications, we should have no objection,' she said.

New medicines are often added to PCT blacklists by default and delays in reviewing them may lead to NICE-approved drugs being blocked.

The group which develops the blacklist for Leicestershire and Rutland currently blacklists the NICE-approved cardiovascular drug ticagrelor. A spokeswoman said this was likely to change following the group's next meeting.

NICE-approved drugs blacklisted by PCTs
  • Cardiovascular: atorvastatin, clopidogrel, dabigatran, ezetimibe, ramipril (tablets), ranolazine, rosuvastatin and ticagrelor.
  • Cancer: erlotinib, mifamurtide and trabectedin.
  • Gastrointestinal: pantoprazole and rabeprazole.
  • Others: asthma (ciclesonide), diabetes (vildagliptin), drug misuse (methadone, some doses), epilepsy (retigabine) and schizophrenia (olanzapine), dexamethasone (corticosteroid).

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Just published

Young doctor

BMA poll could see 'demeaning' junior doctor title ditched

The BMA could drop the term 'junior doctor' in favour of 'resident doctor' to better...

Houses of parliament

Tory peer calls PA fears 'Luddism' and claims most GP visits 'incredibly straightforward'

Most GP appointments are 'incredibly straightforward' and fears over a wider role...

UK money

NHS pension contribution overhaul to go ahead from April

Changes to NHS pension contribution rates, which will see the top earners required...

BMA sign

BMA warns £800m lost from GP contract since 2019 as last-ditch talks continue

BMA negotiators remain in talks over an improved GP contract offer for 2024/25 just...

GP consultation

GPs still under pressure to prescribe black triangle drug inclisiran

GPs are continuing to face pressure to prescribe the black triangle drug inclisiran...

BMA chair Professor Phil Banfield

Lords urged to block legislation for GMC to regulate PAs

The BMA has urged peers to block legislation that would make the GMC responsible...